- ►idsociety.org [PDF] MS Hirsch, F Brun-Vézinet, B Clotet, B … - Clinical Infectious Diseases, 2003 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 455 - Related articles - BL Direct - All 26 versions
- ►pnas.org GM Ortiz, M Wellons, J Brancato, HTT Vo, RL … - Proceedings of the National Academy of Sciences, 2001 - National Acad Sciences The risks and benefits of structured treatment interruption (STI) in
HIV-1-infected subjects are not fully understood. A pilot study was performed to
compare STI with continuous highly active antiretroviral therapy (HAART) in ... Cited by 124 - Related articles - BL Direct - All 10 versions
- ►nih.gov CD Pilcher, MS Cohen - Journal of Clinical Investigation, 2004 - Am Soc Clin Investig The natural history of HIV infection encompasses an acute/primary phase that
lasts months, followed by an early/clinically latent phase that typically lasts
3–10 years, and ultimately by the immune collapse characterized by AIDS. ... Cited by 80 - Related articles - BL Direct - All 9 versions
M Altfeld, BD Walker - Nature medicine, 2001 - ncbi.nlm.nih.gov 1: Nat Med. 2001 Aug;7(8):881-4. Less is more? STI in acute and chronic
HIV-1 infection. Altfeld M, Walker BD. Partners AIDS Research ... Cited by 50 - Related articles - BL Direct - All 3 versions
- ►infekt.ch [PDF] P Taffé, M Rickenbach, B Hirschel, M Opravil … - AIDS, 2002 - journals.lww.com From the Coordination and Data Center, Swiss HIV Cohort Study, Lausanne
University Hospital, Lausanne, the a Division of Infectious Diseases, Geneva
University Hospital, Geneva, the b Division of Infectious Diseases and ... Cited by 40 - Related articles - BL Direct - All 6 versions
LJ Montaner - Trends in immunology, 2001 - Elsevier The realization that HIV-1 is continually replicating in spite of effective
anti-retroviral therapy, the identified toxicities of long-term highly active
antiretroviral therapy (HAART), the difficulties with long-term adherence ... Cited by 35 - Related articles - All 6 versions
- ►adisonline.com [PDF] RM Gulick - Drugs, 2002 - ingentaconnect.com Abstract Current antiretroviral regimens are limited by issues of potency,
adherence, toxicity, resistance and cost. With these limitations and the
realisation that erad- ication of HIV infection currently is not possible, ... Cited by 31 - Related articles - BL Direct - All 7 versions
- ►umich.edu [PDF] SH Bajaria, G Webb, M Cloyd, D Kirschner - JAIDS Journal of Acquired Immune Deficiency …, 2002 - journals.lww.com Summary: Understanding the dynamics of naive and memory CD4+ T cells in the
immune response to HIV-1 infection can help elucidate typical disease
progression patterns observed in HIV-1 patients. Although infection markers ... Cited by 30 - Related articles - BL Direct - All 6 versions
- ►hawaii.edu [PDF] B Hirschel - The Lancet Infectious Diseases, 2001 - Elsevier Highly active antiretroviral therapies (HAART) lower morbidity and mortality of
HIV infection, but are unable to eradicate HIV and may cause side-effects.
Planned interruptions of HAART are studied for three reasons: (1) to ... Cited by 28 - Related articles - All 7 versions
BG Brenner, MA Wainberg, D Turner - ebt, 2002 - informahealthcare.com Highly active antiretroviral therapy (HAART) targeting the viral reverse tran-
scriptase and protease enzymes has advanced the treatment of HIV/AIDS.
Nucleoside and non-nucleoside reverse transcriptase inhibitors and protease ... Cited by 26 - Related articles - All 4 versions
